Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

It is believed most humans are ... First Successful Clinical Trial of VU319 Brings Alzheimer's Treatment One Step Closer Dec. 19, 2024 — Phase I clinical trial of a drug was successfully ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Cognitive problems like more diminished attention, but better immediate recall and memory may help predict Lewy body dementia ...

Posdinemab is an investigational monoclonal antibody that targets the mid-domain of Alzheimer's disease-specific ...

In 2010 the World Health Organization (WHO) estimated the global cost of Alzheimer's at $602 billion and trending to increase 85 per cent by 2030, mainly due to increased number of dementia cases ...